See more : Schrödinger, Inc. (SDGR) Income Statement Analysis – Financial Results
Complete financial analysis of FluoGuide A/S (FLUO.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of FluoGuide A/S, a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Risecomm Group Holdings Limited (1679.HK) Income Statement Analysis – Financial Results
- Public Joint Stock Company Magnitogorsk Iron & Steel Works (MAGN.ME) Income Statement Analysis – Financial Results
- Actic Group AB (publ) (ATIC.ST) Income Statement Analysis – Financial Results
- We.Connect SA (ALWEC.PA) Income Statement Analysis – Financial Results
- Lianyou Metals Co., Ltd. (7610.TWO) Income Statement Analysis – Financial Results
FluoGuide A/S (FLUO.ST)
About FluoGuide A/S
FluoGuide A/S, a life science company, engages in the development and sale of surgical solutions in Denmark. Its lead product candidate is FG001, which is in Phase I/II for the treatment of high-grade glioma, as well as Phase II clinical trial for the treatment of lung cancer. The company also develops FG002, which is in preclinical stage that allows surgeons to differentiate cancer from normal tissue during surgery through a novel uPAR-targeted luminescent technology. FluoGuide A/S has an agreement with Linköping University Hospital for the development of FG001 that is in the Phase I/II clinical trial for surgical removal of brain cancer; and a collaboration with Copenhagen University Hospital. The company was incorporated in 2018 and is headquartered in Copenhagen, Denmark.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 423.00K | 6.51M | 9.61M | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 423.00K | 6.51M | 9.61M | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 100.00% | 100.00% | 100.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 24.10M | 20.59M | 20.64M | 8.88M | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 44.08M | 24.10M | 20.59M | 20.64M | 8.88M | 56.73K |
| Other Expenses | 0.00 | 8.36M | 8.22M | 1.52M | 1.76M | 0.00 |
| Operating Expenses | 44.08M | 32.46M | 28.81M | 22.16M | 10.64M | 57.82K |
| Cost & Expenses | 44.08M | 32.46M | 28.81M | 22.16M | 10.64M | 57.82K |
| Interest Income | 69.00K | 0.00 | 216.00 | 51.00 | 965.00 | 0.00 |
| Interest Expense | 0.00 | 175.00K | 216.00K | 51.00K | 965.00K | 0.00 |
| Depreciation & Amortization | 21.00K | 251.00K | 158.00K | 119.00K | 10.64M | 56.73K |
| EBITDA | -43.90M | -32.21M | -28.65M | -22.04M | 0.00 | 0.00 |
| EBITDA Ratio | -10,378.96% | -497.87% | -300.59% | 0.00% | 0.00% | 0.00% |
| Operating Income | -43.66M | -32.67M | -29.05M | -22.14M | -10.74M | -56.73K |
| Operating Income Ratio | -10,321.28% | -501.72% | -302.24% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -218.00K | -629.00K | -461.00K | -25.00K | -965.00K | -1.09K |
| Income Before Tax | -43.88M | -32.84M | -29.27M | -22.19M | -11.71M | -57.82K |
| Income Before Tax Ratio | -10,372.81% | -504.41% | -304.48% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 5.50M | -5.50M | -5.50M | -4.73M | -2.05M | -1.09K |
| Net Income | -38.38M | -27.34M | -23.77M | -17.46M | -9.65M | -57.82K |
| Net Income Ratio | -9,072.58% | -419.94% | -247.27% | 0.00% | 0.00% | 0.00% |
| EPS | -3.22 | -2.33 | -2.15 | -1.78 | -1.49 | -0.09 |
| EPS Diluted | -3.22 | -2.31 | -2.10 | -1.78 | -1.49 | -0.09 |
| Weighted Avg Shares Out | 11.93M | 11.72M | 11.04M | 9.80M | 6.48M | 675.31K |
| Weighted Avg Shares Out (Dil) | 11.93M | 11.81M | 11.32M | 9.80M | 6.48M | 675.31K |
Source: https://incomestatements.info
Category: Stock Reports